Reflecting the Debates of Updating the Prostate Cancer Guidelines

Author:
James L. Mohler
Search for other papers by James L. Mohler in
Current site
Google Scholar
PubMed
Close
 MD
Full access

James L. Mohler, MD, is Chair of the Department of Urologic Oncology, Leader of the Prostate Program, and Professor of Oncology at Roswell Park Cancer Institute. Dr. Mohler also serves as Professor of Urology at the University at Buffalo (UB) School of Medicine and Biomedical Sciences. Dr. Mohler maintains a clinical practice, focusing on prostate cancer and robot-assisted laparoscopic surgery. In addition to serving as chair of the NCCN Prostate Cancer Panel, he has authored more than 150 publications and book chapters, serves on the editorial board of The Prostate and The Journal of Robotic Surgery, and is a reviewer for numerous cancer journals.

  • Collapse
  • Expand
  • 1.

    Howard D H. Life expectancy and the value of early detection. J Health Econ 2005;24:891.

  • 2.

    Epstein JI, Walsh PC, Carmichael M et al.. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271:368.

  • 3.

    Epstein JI, Chan DW, Sokoll LJ et al.. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol 1998;160:2407.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Cheng L, Jones TD, Pan CX et al.. Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol 2005;18:1022.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Cheng L, Poulos CK, Pan CX et al.. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens. J Urol 2005;174:898.

  • 6.

    Choo R, Klotz L, Danjoux C et al.: Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 2002;167:1664.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Menon M, Hemal AK. Vattikuti Institute prostatectomy: a technique of robotic radical prostatectomy: experience in more than 1000 cases. J Endourol 2004;18:611.

  • 8.

    Ahlering TE. Robotic prostatectomy: is it the future? Urol Oncol 2006;24:1.

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 690 247 49
PDF Downloads 121 20 1
EPUB Downloads 0 0 0